Career
Dr. Bing Liang represents biotechnological and pharmaceutical companies on the procurement and protection of intellectual property, particularly in the areas of biologics and diagnostics. Bing drives global intellectual property strategies for high-value innovative medicines, with a proven track record of success creating strategic patent assets covering some of the world's most valuable life-saving medicines, including CARVYKTI®, PALYNZIQ®, PADCEV™, VENCLEXTA®, NUPLAZID®, POMALYST®, REVLIMID®, and OTEZLA®. Bing is highly experienced in intellectual property due diligence for a wide range of transactions, with particular expertise in complex cross-border deals. Bing is adept at navigating multi-jurisdictional intellectual property landscapes and providing strategic insights that support seamless deal execution.